ENDO 2025
12 - 15 July 2025
Real-world Weight Loss Observed With Semaglutide And Tirzepatide In Patients With Overweight Or Obesity And Without Type 2 Diabetes
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.